Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Expert overview of hot news in lymphoma from ASH 2012 (1/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (1/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Multiple myeloma advances for the future suggested by phase I clinical research

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute

Dr Michael Savona - Sarah Cannon Research Institute, Nashville, USA
Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute ( Dr Michael Savona - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Minimally invasive surgery-role for the liver?

Dr. Allan Tsung - University of Pittsburgh Schools of the Health Sciences, United States
Minimally invasive surgery-role for the liver?  ( Dr. Allan Tsung - University of Pittsburgh Schools of the Health Sciences, United States )
19 Dec 2012

Lateral pelvic lymph node dissection

Dr Wai Choi - University of Hong Kong
Lateral pelvic lymph node dissection  ( Dr Wai Choi - University of Hong Kong )
19 Dec 2012

Highlights on multiple myeloma from ASH 2012

Professor Michel Delforge, Professor Meletios Dimopoulos
Highlights on multiple myeloma from ASH 2012 ( Professor Michel Delforge, Professor Meletios Dimopoulos )
18 Dec 2012

Expert overview of CLL from ASH 2012

Professor John Gribben, Professor Peter Hillman, Professor Kanti Rai
Expert overview of CLL from ASH 2012 ( Professor John Gribben, Professor Peter Hillman, Professor Kanti Rai )
18 Dec 2012